Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: PET-CT as standard for FDG-avid lymphomas | Statement: [Lugano classification, recommends, PET-CT as standard for FDG-avid lymphomas]

Target entity: PET-CT as standard for FDG-avid lymphomas
Context triple: [Lugano classification, recommends, PET-CT as standard for FDG-avid lymphomas]

• A. non-Hodgkin lymphoma
  Non-Hodgkin lymphoma is a diverse group of blood cancers that originate in the lymphatic system from abnormal lymphocytes and can vary widely in aggressiveness and prognosis.
• B. Hodgkin lymphoma
  Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, characterized by the presence of abnormal Reed–Sternberg cells and often affecting lymph nodes.
• C. ABVD regimen
  The ABVD regimen is a standard chemotherapy combination used as first-line treatment for classical Hodgkin lymphoma.
• D. Leukemia and Lymphoma Research
  Leukemia and Lymphoma Research is a UK-based medical research charity dedicated to improving the diagnosis, treatment, and prevention of blood cancers such as leukemia and lymphoma.
• E. Hodgkin
  Hodgkin is a surname most famously associated with Dorothy Hodgkin, the Nobel Prize–winning British chemist who advanced the field of X-ray crystallography.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: PET-CT as standard for FDG-avid lymphomas
Triple: [Lugano classification, recommends, PET-CT as standard for FDG-avid lymphomas]

PET-CT as standard for FDG-avid lymphomas refers to the use of fluorodeoxyglucose positron emission tomography combined with computed tomography as the primary imaging modality for staging and response assessment in lymphomas that avidly take up FDG.

Target entity: PET-CT as standard for FDG-avid lymphomas
Target entity description: PET-CT as standard for FDG-avid lymphomas refers to the use of fluorodeoxyglucose positron emission tomography combined with computed tomography as the primary imaging modality for staging and response assessment in lymphomas that avidly take up FDG.

• A. non-Hodgkin lymphoma
  Non-Hodgkin lymphoma is a diverse group of blood cancers that originate in the lymphatic system from abnormal lymphocytes and can vary widely in aggressiveness and prognosis.
• B. Hodgkin lymphoma
  Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, characterized by the presence of abnormal Reed–Sternberg cells and often affecting lymph nodes.
• C. ABVD regimen
  The ABVD regimen is a standard chemotherapy combination used as first-line treatment for classical Hodgkin lymphoma.
• D. Leukemia and Lymphoma Research
  Leukemia and Lymphoma Research is a UK-based medical research charity dedicated to improving the diagnosis, treatment, and prevention of blood cancers such as leukemia and lymphoma.
• E. Hodgkin
  Hodgkin is a surname most famously associated with Dorothy Hodgkin, the Nobel Prize–winning British chemist who advanced the field of X-ray crystallography.
• F. None of above. chosen